Skip to content
RUO · Research Use OnlyAnti-Inflammatory✓ Free to read

KPV

Also called Lysine-Proline-Valine

A tiny three-piece peptide people try to calm gut and skin inflammation, with no real human proof yet.

Updated 03 May 2026Read 3 minBacked by 36 studies
The quick version
What it is
A three-amino-acid piece of a natural body hormone
Is it FDA-approved?
No, sold for research only
How strong is the proof?
Weak in people: good animal data, zero finished human trials
How you take it
The studied route is oral; many also inject it
Typical result
Calms gut inflammation in animals; unproven in people
Biggest catch
No human trial has ever shown it works

Any word with a dotted underline is a science word — tap it for a plain-English meaning.

In plain words.

KPV gets its name straight from its three building blocks: lysine, proline, and valine. Those building blocks are called amino acids, and three of them is about as small as a gets.

It is the tail end of a natural body hormone called alpha-MSH. In animals, KPV calms down inflammation. That is most clear in the gut and the skin.

It is not . It is sold for research only. People often pick it as a quieter, less-hyped cousin of BPC-157.

What people use it for.

People mostly try KPV for gut inflammation, like mild IBD (inflammatory bowel disease). Some try it for inflamed skin.

It is often sold to the "leaky gut" crowd. Be careful there. "Leaky gut" on its own is not a real, tested diagnosis. The right first step is a proper gut workup with a doctor.

Does it actually work?

Nobody has actually run the test in people. That is the part sellers skip.

There are zero finished randomized human trials. There are only a handful of small case reports in people, maybe 6.

The animal data is the strong part. About 25 animal studies on gut inflammation (colitis) line up fairly well. In those, KPV cooled the inflammation down.

So: promising in mice, unproven in people. Do not let a seller tell you it is a sure thing.

what you’ve probably heard.

The claims floating around online, and how true they actually are.

It heals leaky gut.

unproven

"Leaky gut" on its own is not a real, tested diagnosis, and there are zero finished human trials of KPV for it. You would have no clean way to tell if it did anything.

It's a gentler, safer BPC-157.

half true

It is sold as the quieter, less-hyped cousin, and that is fair. But quieter on hype is not the same as proven. Both share the same hole: no finished human trial.

It clears up inflamed skin.

unproven

KPV comes from alpha-MSH, a natural calm-down signal for skin, and in animals it does cool skin inflammation. But no finished human trial backs the skin use.

You have to inject it for it to work.

myth

Backwards. The animal proof is for KPV swallowed, which slips in through a gut door called PepT1. A shot solves no problem it is absorbed fine by mouth.

How you take it.

The animal proof is for KPV taken by mouth (oral). Your gut has a built-in door called PepT1 that lets KPV in. So oral capsules are the route the science is actually from.

A lot of people inject it instead. But KPV is absorbed fine by mouth, so a shot does not solve any problem. There is no human dose ladder with trial backing.

If you do try it, capsules are the only version with logic behind them, and there is no trial-backed dose to copy. Set a cutoff date before you start, so a "maybe it is working" feeling does not turn into a year of paying for nothing.

What to watch out for.

There are no scary "black box" safety alarms on KPV. There is also no proof it works in people.

A few reasons to be careful: - Skip it if you have active autoimmune skin disease, like rosacea or vitiligo. - Skip it if you have a melanocortin-system problem or a recent melanoma history. KPV touches that same hormone system. This worry is theoretical, with no human cases reported, but worth knowing.

Most important: get a real gut workup first. KPV will not fix a missed celiac or Crohn's diagnosis. Talk to a real doctor. We are not your doctor.

Where people get it.

Here are the lanes, safest to riskiest.

  • Brand. None. No KPV exists.
  • . Some pharmacies still make it with a prescription, about $80–$200 a month. Its legal footing got shaky after late 2024.
  • Research-only (). This is the main source. Cheap, about $25–$70 a month. KPV is tiny and easy to make.
  • . Overseas raw, around $10 a month. Paid by crypto, no lab report, sold in boxes of ten vials.

Whatever lane you pick, ask for a . That is a lab report showing what is really in the vial.

Our honest take.

Strip away the marketing and the gut data is almost all in mice, with not one finished human trial to point to. You would be the trial.

The animal story is real enough to be interesting, not strong enough to promise you anything. You will also have no clean way to tell whether a flare calmed down because of KPV or because it was going to calm down anyway.

So treat it like an experiment, not a treatment. Get a real gut workup first, because KPV will not fix a missed Crohn's or celiac, and do not let it stand in for the IBD medicine that actually has proof behind it.

The studies behind this.

We read the research so you don't have to. Here's where the facts on this page come from.

  1. 01Zhang L, et al. KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy. Advanced healthcare materials. 2024;13(32):e2402320. PMID: 39252648.
  2. 02Pawar K, et al. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. Journal of pharmaceutical sciences. 2017;106(7):1814-1820. PMID: 28343991.
  3. 03Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-78. PMID: 18061177.
  4. 04Zeng K, et al. NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development. Cell death and differentiation. 2026;33(2):343-357. PMID: 40935835.
  5. 05Elliott RJ, et al. alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. The Journal of investigative dermatology. 2004;122(4):1010-9. PMID: 15102092.
  6. 06Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory bowel diseases. 2008;14(3):324-31. PMID: 18092346.
  7. 07Sung J, et al. Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Tissue & cell. 2025;95:102837. PMID: 40073467.
  8. 08Pawar KR, et al. Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. Biomedical chromatography : BMC. 2015;29(5):716-21. PMID: 25298219.
  9. 09Getting SJ, et al. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. The Journal of pharmacology and experimental therapeutics. 2003;306(2):631-7. PMID: 12750433.
  10. 10Songok AC, et al. Structural modification of the tripeptide KPV by reductive "glycoalkylation" of the lysine residue. PloS one. 2018;13(6):e0199686. PMID: 29953505.
  11. 11Xiao B, et al. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Molecular therapy : the journal of the American Society of Gene Therapy. 2017;25(7):1628-1640. PMID: 28143741.
  12. 12Zhao Y, et al. A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon. Acta biomaterialia. 2022;143:233-252. PMID: 35245681.
  13. 13Luger TA, et al. New insights into the functions of alpha-MSH and related peptides in the immune system. Annals of the New York Academy of Sciences. 2003;994:133-40. PMID: 12851308.
  14. 14Catania A, et al. The neuropeptide alpha-MSH in host defense. Annals of the New York Academy of Sciences. 2000;917:227-31. PMID: 11268348.
  15. 15Sun J, et al. Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats. ACS biomaterials science & engineering. 2021;7(10):4859-4869. PMID: 34547895.
  16. 16Ichiyama T, et al. The neuroimmunomodulatory peptide alpha-MSH. Annals of the New York Academy of Sciences. 2000;917:221-6. PMID: 11268347.
  17. 17Zeng M, et al. Peptide Receptor-Targeted Fluorescent Probe: Visualization and Discrimination between Chronic and Acute Ulcerative Colitis. ACS applied materials & interfaces. 2017;9(15):13029-13036. PMID: 28349696.
  18. 18Shao W, et al. In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis. Biomaterials science. 2021;10(1):227-242. PMID: 34846053.
  19. 19Land SC. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. International journal of physiology, pathophysiology and pharmacology. 2012;4(2):59-73. PMID: 22837805.
  20. 20Brzoska T, et al. Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Advances in experimental medicine and biology. 2010;681:107-16. PMID: 21222263.
  21. 21Laroui H, et al. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology. 2010;138(3):843-53.e1-2. PMID: 19909746.
  22. 22Bonfiglio V, et al. Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Experimental eye research. 2006;83(6):1366-72. PMID: 16965771.
  23. 23Sun MC, et al. Biomimetic Melanosomes Promote Orientation-Selective Delivery and Melanocyte Pigmentation in the H(2)O(2)-Induced Vitiligo Mouse Model. ACS nano. 2021;15(11):17361-17374. PMID: 34662120.
  24. 24Gravina AG, et al. The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials. Cells. 2023;12(14). PMID: 37508552.
  25. 25Gatti S, et al. Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions. The Journal of surgical research. 2006;131(2):209-14. PMID: 16413580.
  26. 26Viennois E, et al. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. Cellular and molecular gastroenterology and hepatology. 2016;2(3):340-357. PMID: 27458604.
  27. 27Böhm M, et al. Are melanocortin peptides future therapeutics for cutaneous wound healing?. Experimental dermatology. 2019;28(3):219-224. PMID: 30661264.
  28. 28Luger TA, et al. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Annals of the rheumatic diseases. 2007;66 Suppl 3(Suppl 3):iii52-5. PMID: 17934097.
  29. 29Macaluso A, et al. Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1994;14(4):2377-82. PMID: 8158274.
  30. 30Richards DB, et al. Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit. Peptides. 1984;5(4):815-7. PMID: 6333677.
  31. 31Brzoska T, et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine reviews. 2008;29(5):581-602. PMID: 18612139.
  32. 32Rodrigues JM, et al. Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease. Drug discovery today. 2025;30(12):104535. PMID: 41241376.
  33. 33Zhang D, et al. PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS. Frontiers in pharmacology. 2024;15:1442876. PMID: 39211778.
  34. 34Barcellini W, et al. Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. Journal of leukocyte biology. 2000;68(5):693-9. PMID: 11073109.
  35. 35Kelly JM, et al. Immobilized alpha-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-alpha stimulated NF-kappaB activity. Peptides. 2006;27(2):431-7. PMID: 16274845.
  36. 36Carotenuto A, et al. Structure-function relationships and conformational properties of alpha-MSH(6-13) analogues with candidacidal activity. Chemical biology & drug design. 2007;69(1):68-74. PMID: 17313459.

We're not your doctor, and this isn't medical advice. It's a plain-English summary of what the research says, so you can have a smarter conversation with someone who is.

Keep up with this stuff

Want the rest of the peptide world, in plain English?

New breakdowns, safety updates, and what's actually worth your money. Free. Unsubscribe in one click.